BRPI0918134A2 - derivado de prostaglandina i2 - Google Patents
derivado de prostaglandina i2Info
- Publication number
- BRPI0918134A2 BRPI0918134A2 BRPI0918134A BRPI0918134A BRPI0918134A2 BR PI0918134 A2 BRPI0918134 A2 BR PI0918134A2 BR PI0918134 A BRPI0918134 A BR PI0918134A BR PI0918134 A BRPI0918134 A BR PI0918134A BR PI0918134 A2 BRPI0918134 A2 BR PI0918134A2
- Authority
- BR
- Brazil
- Prior art keywords
- prostaglandin
- derivative
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2008-232133 | 2008-09-10 | ||
| JP2008232133 | 2008-09-10 | ||
| JP2009168193 | 2009-07-16 | ||
| JP2009-168193 | 2009-07-16 | ||
| PCT/JP2009/065690 WO2010029925A1 (ja) | 2008-09-10 | 2009-09-08 | 新規なプロスタグランジンｉ２誘導体 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| BRPI0918134A2 true BRPI0918134A2 (pt) | 2016-03-01 |
| BRPI0918134B1 BRPI0918134B1 (pt) | 2019-02-12 |
Family
ID=42005178
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BRPI0918134-2A BRPI0918134B1 (pt) | 2008-09-10 | 2009-09-08 | Derivado de prostaglandina i2 |
Country Status (15)
| Country | Link |
|---|---|
| US (4) | US8394844B2 (pt) |
| EP (1) | EP2343292B1 (pt) |
| JP (1) | JP5468007B2 (pt) |
| KR (1) | KR101645752B1 (pt) |
| CN (1) | CN102209719B (pt) |
| AU (1) | AU2009292555B2 (pt) |
| BR (1) | BRPI0918134B1 (pt) |
| CA (1) | CA2736039C (pt) |
| DK (1) | DK2343292T3 (pt) |
| ES (1) | ES2522971T3 (pt) |
| MX (1) | MX2011002573A (pt) |
| PL (1) | PL2343292T3 (pt) |
| PT (1) | PT2343292E (pt) |
| RU (1) | RU2509768C2 (pt) |
| WO (1) | WO2010029925A1 (pt) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2736039C (en) | 2008-09-10 | 2016-06-07 | Asahi Glass Co Ltd | Novel prostaglandin i2 derivative |
| KR20170024165A (ko) | 2009-06-26 | 2017-03-06 | 니뽄 신야쿠 가부시키가이샤 | 결정 |
| CN102917703B (zh) * | 2010-03-08 | 2015-08-19 | 科研制药株式会社 | 新型ep4激动剂 |
| ES2637286T3 (es) * | 2011-07-08 | 2017-10-11 | Defensin Therapeutics Aps | Tratamiento oral de la enfermedad inflamatoria intestinal |
| IN2015DN02814A (pt) * | 2012-10-26 | 2015-09-11 | Asahi Glass Co Ltd | |
| JP6694385B2 (ja) | 2013-08-09 | 2020-05-13 | アーデリクス，インコーポレーテッド | リン酸塩輸送阻害のための化合物及び方法 |
| EP3282937A4 (en) * | 2015-04-14 | 2018-11-21 | Nueon Inc. | Method and apparatus for determining markers of health by analysis of blood |
| CN114340631A (zh) | 2019-05-21 | 2022-04-12 | 阿德利克斯股份有限公司 | 用于降低患者的血清磷酸盐的组合 |
| WO2021070658A1 (ja) * | 2019-10-11 | 2021-04-15 | 国立大学法人東北大学 | シクロペンタン化合物の製造方法、ラクトン化合物の製造方法、ジオール化合物の製造方法、および化合物 |
| HU231350B1 (hu) | 2019-12-18 | 2023-01-28 | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt | Eljárás királis prosztaglandin-enol intermedier előállítására, és az eljárásban hasznos köztitermék vegyületek |
| CN119212700A (zh) | 2022-05-16 | 2024-12-27 | Ａｇｃ株式会社 | IL-6和/或IL-1β抑制剂 |
| GB202211232D0 (en) | 2022-08-02 | 2022-09-14 | Heptares Therapeutics Ltd | Prostaglandin EP4 receptor agonist compounds |
Family Cites Families (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE788209A (fr) | 1971-09-01 | 1973-02-28 | Pfizer | Derives tetrazoyliques des prostaglandines naturelles |
| NL7401493A (pt) | 1973-02-08 | 1974-08-12 | ||
| US4705806A (en) * | 1978-02-13 | 1987-11-10 | Morton Jr Douglas R | Prostacyclin analogs |
| US4565827A (en) * | 1980-10-27 | 1986-01-21 | Chinoin Gyogyszer Es Vegyeszeti Termekek Gyara R.T. | 7-Substituted PGI2 -derivatives and pharmaceutical compositions containing them |
| KR970002877B1 (ko) | 1987-07-17 | 1997-03-12 | 더 누트라스웨트 캄파니 | 고성능 감미제 |
| WO1990000552A1 (en) * | 1988-07-12 | 1990-01-25 | The Nutrasweet Company | High potency sweetening agents |
| US4881288A (en) * | 1988-07-13 | 1989-11-21 | Tennant Trend Inc. | Center feed dispenser for cleaning solution |
| JP2500371B2 (ja) | 1993-11-08 | 1996-05-29 | 工業技術院長 | 半導体薄膜の成長方法 |
| DE69531110T2 (de) | 1994-02-17 | 2004-05-19 | Asahi Glass Co., Ltd. | Difluoroprostacycline, Zwischenprodukte zu deren Herstellung und Herstellungsverfahren |
| JP3719524B2 (ja) | 1994-03-17 | 2005-11-24 | 旭硝子株式会社 | ジハロゲン化プロスタサイクリン類の製造方法 |
| JP3769738B2 (ja) | 1994-04-11 | 2006-04-26 | 旭硝子株式会社 | ジフルオロプロスタサイクリン類 |
| JPH08217772A (ja) | 1995-02-13 | 1996-08-27 | Asahi Glass Co Ltd | ジフルオロ置換ビニルエーテル類の製造方法 |
| TW401408B (en) | 1995-07-21 | 2000-08-11 | Fujisawa Pharmaceutical Co | Heterocyclic compounds having prostaglandin I2 agonism |
| JP3598611B2 (ja) | 1995-10-17 | 2004-12-08 | 旭硝子株式会社 | ジフルオロ化合物の製造方法 |
| WO1997017974A1 (en) | 1995-11-14 | 1997-05-22 | Toray Industries, Inc. | Ocular depressor |
| TW416953B (en) | 1996-09-25 | 2001-01-01 | Takeda Chemical Industries Ltd | Tricyclic compounds for eliciting a prostaglandin I2 receptor agonistic effect, their production and use |
| AUPO440696A0 (en) | 1996-12-30 | 1997-01-23 | Fujisawa Pharmaceutical Co., Ltd. | New use |
| WO1998041209A1 (fr) | 1997-03-14 | 1998-09-24 | Toray Industries, Inc. | Agents protecteurs de la cellule nerveuse |
| IT1299191B1 (it) | 1998-06-23 | 2000-02-29 | Sigma Tau Healthscience Spa | Composizione atta a prevenire e trattare l'osteoporosi e le alterazioni legate alla menopausa |
| CN1216050C (zh) | 1998-10-23 | 2005-08-24 | 东丽株式会社 | 5,6,7－三去甲－4,8－内－间亚苯基pgi2衍生物及含有其的医药 |
| MXPA04000456A (es) * | 2001-07-16 | 2004-03-18 | Hoffmann La Roche | Analogos de prostaglandina como agonistas del receptor ep4. |
| EP1481976B1 (en) * | 2002-03-05 | 2012-11-07 | Ono Pharmaceutical Co., Ltd. | 8-azaprostaglandin derivative compounds and drugs containing the compounds as the active ingredient |
| WO2003103664A1 (en) | 2002-06-06 | 2003-12-18 | Merck Frosst Canada & Co. | 1,5-disubstituted imidazolidin-2-one derivatives for use as ep4 receptor agonists in the treatment of eye and bone diseases |
| JP5007169B2 (ja) | 2007-02-20 | 2012-08-22 | カルソニックカンセイ株式会社 | 電動コンプレッサ |
| EP1988087A1 (en) | 2007-03-28 | 2008-11-05 | Bayer Schering Pharma Aktiengesellschaft | Novel 5-cyano-prostacyclin derivatives and their use as agents for the treatment of autoimmune diseases |
| JP2009168193A (ja) | 2008-01-18 | 2009-07-30 | Nachi Fujikoshi Corp | 遊星歯車減速機 |
| CA2736039C (en) | 2008-09-10 | 2016-06-07 | Asahi Glass Co Ltd | Novel prostaglandin i2 derivative |
-
2009
- 2009-09-08 CA CA2736039A patent/CA2736039C/en active Active
- 2009-09-08 AU AU2009292555A patent/AU2009292555B2/en not_active Ceased
- 2009-09-08 RU RU2011113967/04A patent/RU2509768C2/ru active
- 2009-09-08 DK DK09813071.9T patent/DK2343292T3/da active
- 2009-09-08 MX MX2011002573A patent/MX2011002573A/es active IP Right Grant
- 2009-09-08 PL PL09813071T patent/PL2343292T3/pl unknown
- 2009-09-08 EP EP09813071.9A patent/EP2343292B1/en active Active
- 2009-09-08 KR KR1020117007958A patent/KR101645752B1/ko active Active
- 2009-09-08 JP JP2010528724A patent/JP5468007B2/ja active Active
- 2009-09-08 PT PT98130719T patent/PT2343292E/pt unknown
- 2009-09-08 BR BRPI0918134-2A patent/BRPI0918134B1/pt active IP Right Grant
- 2009-09-08 CN CN200980144732.5A patent/CN102209719B/zh active Active
- 2009-09-08 WO PCT/JP2009/065690 patent/WO2010029925A1/ja not_active Ceased
- 2009-09-08 ES ES09813071.9T patent/ES2522971T3/es active Active
-
2010
- 2010-11-02 US US12/917,935 patent/US8394844B2/en active Active
-
2012
- 2012-11-13 US US13/675,530 patent/US8691857B2/en active Active
-
2014
- 2014-01-09 US US14/151,479 patent/US8877787B2/en active Active
- 2014-09-26 US US14/498,429 patent/US9034906B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| AU2009292555A1 (en) | 2010-03-18 |
| US8877787B2 (en) | 2014-11-04 |
| WO2010029925A1 (ja) | 2010-03-18 |
| EP2343292B1 (en) | 2014-08-06 |
| RU2011113967A (ru) | 2012-10-27 |
| AU2009292555B2 (en) | 2014-05-29 |
| DK2343292T3 (da) | 2014-11-03 |
| US20130072530A1 (en) | 2013-03-21 |
| RU2509768C2 (ru) | 2014-03-20 |
| KR101645752B1 (ko) | 2016-08-04 |
| JPWO2010029925A1 (ja) | 2012-02-02 |
| MX2011002573A (es) | 2011-07-28 |
| US20150018401A1 (en) | 2015-01-15 |
| PL2343292T3 (pl) | 2015-01-30 |
| CN102209719B (zh) | 2014-05-14 |
| CN102209719A (zh) | 2011-10-05 |
| US8394844B2 (en) | 2013-03-12 |
| US9034906B2 (en) | 2015-05-19 |
| EP2343292A4 (en) | 2012-03-21 |
| US8691857B2 (en) | 2014-04-08 |
| CA2736039A1 (en) | 2010-03-18 |
| PT2343292E (pt) | 2014-11-04 |
| US20110098481A1 (en) | 2011-04-28 |
| US20140128441A1 (en) | 2014-05-08 |
| EP2343292A1 (en) | 2011-07-13 |
| ES2522971T3 (es) | 2014-11-19 |
| KR20110051286A (ko) | 2011-05-17 |
| BRPI0918134B1 (pt) | 2019-02-12 |
| JP5468007B2 (ja) | 2014-04-09 |
| CA2736039C (en) | 2016-06-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2376493A4 (en) | DIHYDROPYRIMIDOPYRIMIDINDERIVAT | |
| EP2380877A4 (en) | PYRIDINE-3-CARBONSÄUREAMIDDERIVAT | |
| EP2336132A4 (en) | MORPHOLINPURINDERIVAT | |
| DK2308877T3 (da) | Imidazopyridin-2-on-derivater | |
| EP2433940A4 (en) | SPIROIMIDAZOLONDERIVAT | |
| DK2340021T3 (da) | Substituerede pyrrolidin-2-carboxamider | |
| BRPI0915064A2 (pt) | derivados de qunoxalinadiona | |
| EP2226315A4 (en) | 2-aminoquinazoline DERIVATIVE | |
| DK2288375T3 (da) | Pegylerede insulin-lispro-forbindelser | |
| BRPI0920707A2 (pt) | compostos | |
| DK2242759T3 (da) | Forbindelser | |
| BRPI0913832A2 (pt) | derivados de pirrolopiridinilpirimidin-2-ilamina | |
| EP2397480A4 (en) | DIAZEPINEDIONEDERIVATE | |
| ECSP12011999A (es) | Derivados benzamida sustituidos | |
| BRPI0918134A2 (pt) | derivado de prostaglandina i2 | |
| EP2344471A4 (en) | 7-PIPERIDINALKYL-3,4-dihydroquinolone DERIVATIVE | |
| DK2323972T3 (da) | C7-fluor-substituerede tetracylinforbindelser | |
| DK2275414T3 (da) | Cyclopentylacrylamidderivat | |
| DK2297162T3 (da) | Forbindelser | |
| BRPI0906888A2 (pt) | derivado de fenilacetamida | |
| ATE545635T1 (de) | Substituierte n-oxidpyrazinderivate | |
| EP2495246A4 (en) | FULLER DERIVATIVE | |
| BRPI0913234A2 (pt) | derivados de tiazolilpiperidina | |
| EP2401281A4 (en) | PYRIMIDINPYRIMIDOINDAZOLDERIVAT | |
| BRPI0922652A2 (pt) | Derivados de quinazolinamida |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B07D | Technical examination (opinion) related to article 229 of industrial property law | ||
| B06F | Objections, documents and/or translations needed after an examination request according art. 34 industrial property law | ||
| B07E | Notice of approval relating to section 229 industrial property law | ||
| B07A | Technical examination (opinion): publication of technical examination (opinion) | ||
| B25D | Requested change of name of applicant approved |
Owner name: KAKEN PHARMACEUTICAL CO., LTD (JP) ; AGC INC. (JP) |
|
| B09A | Decision: intention to grant | ||
| B16A | Patent or certificate of addition of invention granted |
Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/09/2009, OBSERVADAS AS CONDICOES LEGAIS. (CO) 20 (VINTE) ANOS CONTADOS A PARTIR DE 08/09/2009, OBSERVADAS AS CONDICOES LEGAIS |
|
| B25A | Requested transfer of rights approved |
Owner name: AGC INC. (JP) |
|
| B25G | Requested change of headquarter approved |
Owner name: AGC INC. (JP) |